ERIC DOBMEIER - 14 Dec 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role: President, CEO, Director
Signature: /s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 14 Dec 2022
Net transactions value: +$10,500
Form type: 4
Filing time: 15 Dec 2022, 15:27:32 UTC
Previous filing: 02 Dec 2022
Next filing: 01 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KDNY	Common Stock	Options Exercise	$10,500	+30,000	+12%	$0.3500^*	271,676	14 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KDNY	Stock Option (Right to Buy)	Options Exercise	$0	-30,000	-7.8%	$0.000000	353,358	14 Dec 2022	Common Stock	30,000	$0.3500	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vested as to 25% of the total shares on April 1, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.